(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This topical volume provides an overview of clinically relevant data on anticancer agents. It is not only intended medical doctors working with cancer patients, and for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds.
Contents:
Antimetabolites.- DNA-intercalators - the anthracyclines.- Topoisomerase inhibitors.- Tubulin interacting agents.- Vaccination therapies in solid tumors.- Oral anticancer agents.- Anti-angiogenesis agents.- Signal transduction inhibitors.- Endocrine therapy of breast cancer.
PRODUCT DETAILS
Publisher: Springer (Birkhauser Verlag AG)
Publication date: June, 2006
Pages: 246
Weight: 598g
Availability: Available
Subcategories: Immunology, Oncology, Pharmacology
From the same series
V. Craig Jordan
Antonio Guglietta
Mark von Itzstein
Maryann Foote
Henry M. Staines
Munther A. Khamashta
Alexandre Trifilieff
Lars Olbe
V. Craig Jordan
Christoph C. Zielinski
H.-J. Schuurman
Eric Ertel
Michel Pairet
Michael Torzewski
Joseph M. Colacino
Bruce N. Cronstein
David Nutt
Udo Dunzendorfer
Allan R. Ronald
Alexander R. Cools
Erik De Clercq
Jerry J. Buccafusco
Roderick J. Flower
Brian E. Leonard
W. Schönfeld
P. Buckel
Wolfgang Loscher
Pedro D'Orléans-Juste
Yuti Chernajovsky
Maryann Foote
Henry M. Staines
Mark von Itzstein
Christoph C. Zielinski
Kenneth C. Anderson
Phil Skolnick
Yuti Chernajovsky
Francesco M. Veronese
Husseini K. Manji
Jeffrey M. Weinberg
William R. Miller
John P. H. Wilding
Jacqueline D. Reeves
Jeffrey M. Weinberg